Geneva University Hospital
Geneva, 1205, Switzerland
NCT Number: NCT02461147
Initial cholecystectomy with intraoperative cholangiogram, followed if required by ERCP, has been implemented at the investigators institution as the standard management strategy for patients at intermediate risk of common bile duct stone migration, following a randomized controlled trial previously published by the same investigators team. The aim of this study is to prospectively analyze the outcomes of this strategy.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Geneva, 1205, Switzerland
A previous randomized controlled trial comparing initial cholecystectomy with intraoperative cholangiogram (IOC) versus common bile duct (CBD) assessment and subsequent cholecystectomy for patients admitted in the emergency room with an acute gallstone-related condition and with an intermediate risk of common bile duct stone was performed by the investigators. This study had been registered on Clinicaltrials.gov as well and had shown that a strategy with initial cholecystectomy significantly decreased the length of hospital stay and the number of CBD investigations procedures.
Initial cholecystectomy with IOC is now the standard management strategy for these patients in the investigators hospital. The goal of this study is to perform a prospective validation of this strategy and to analyze if the results obtained in the previously mentioned randomized controlled trial are confirmed on a larger patients cohort. This study will be observational, since the intervention (initial cholecystectomy) is not assigned by the investigators, but is already a standard treatment strategy at our institution.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cf. arm/group description. This intervention is not assigned by the investigators: it is the standard treatment at the investigators institution.
Time frame: 1-100 days
Time frame: Anytime during hospital stay, an expected average of 7 days
These include number of endoscopic ultrasounds (EUS), magnetic cholangio-pancreatography (MRCP) and endoscopic retrograde cholangio-pancreatography (ERCP) performed during the patient's hospital stay
Time frame: This outcome will be assessed after each ERCP performed during hospital stay, an expected average of 7 days
Percentage of patients where common bile duct (CBD) clearance was achieved after ERCP (did not require surgical exploration because of ERCP failure)
Time frame: From admission up to 6 months after hospital discharge
Morbidity will be assessed for each patient according to the Dindo-Clavien classification of surgical complications, including death.
University Hospital, Geneva
Other
Initial Cholecystectomy With Intraoperative Cholangiography for Patients at Intermediate Risk of Common Bile Duct Stone Migration : Prospective Validation and Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06111872
Bile Duct Diseases, Biliary Tract Diseases
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT04716166
Benign Pancreas Tumor, Bile Duct Diseases
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT02037958
Bile Duct Diseases, Biliary Tract Diseases
Singapore
View Trial DetailsNCT01824186
Bile Duct Diseases, Biliary Tract Diseases
Singapore
View Trial Details